Recent news on Enjuvia

Duramed's Enjuvia Tablets Receives Two New FDA Approvals  -  May 8, 2007
SpiritIndia,In addition, ENJUVIA is also the first and only oral estrogen that has been approved by FDA to treat moderate-to-severe vaginal dryness and pain with

Duramed's ENJUVIA Tablets Receives Two New FDA Approvals  -  Apr 30, 2007
eMaxHealth.com,Duramed Pharmaceuticals announced that the Company has received two US Food and Drug Administration approvals related to its ENJUVIA (synthetic conjugated

New Dosage Strength and Indication Approved for Enjuvia  -  Apr 30, 2007
Facts and Comparisons,The FDA has issued 2 approvals related to Duramed Pharmaceuticals’ Enjuvia (synthetic conjugated estrogens, B). The FDA has approved the company's SNDA for

Duramed wins additional FDA approvals for estrogen product  -  Apr 30, 2007
Cincinnati Business Courier,Enjuvia had previously been approved for four tablet dosages, and for vasomotor symptoms associated with menopause, the company said in a news release.

Market Report -- In Play (BRL)  -  Apr 30, 2007
MSN MoneyBarr Pharma: Duramed's Enjuvia tablets receives two new FDA approvals Co announces it has received two FDA approvals related to its Enjuvia product.

New Jersey briefs  -  May 1, 2007
NorthJersey.com,The FDA has approved the company's new drug application for 0.9 milligram tablet strength, which will be added to Duramed's Enjuvia product line that

Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Now ...  -  Apr 12, 2007
Drug Newswire (press release),The Company began shipping ENJUVIA in April and today is initiating its professional communication to physicians at the American College of Obstetricians

Barr Reports Third Quarter Fiscal 2006 GAAP Earnings of $0.70 Per ...  -  Apr 12, 2007
Drug Newswire (press release),We also invested in preparing for the launch of our Enjuvia(TM) hormone therapy product line in April and submitted our labeling for our SEASONIQUE(TM)

Barr Reports Second Quarter Fiscal 2006 GAAP Earnings of $0.88 Per ...  -  Apr 12, 2007
Drug Newswire (press release),...through television and print advertising and began preparations for the anticipated launch of our Enjuvia(TM) hormone therapy product later this year."

Sector Snap: Drug Makers  -  Mar 27, 2007
Houston Chronicle,Wyeth sells the hormone replacement therapies Premarin and Prempro, while Barr sells Enjuvia. Traditional estrogen replacement has come under fire for

Medpharm: FDA approves Plan B, who owns it?  Aug 25, 2006
This includes five oral contraceptives, including Plan B, and ENJUVIA, a once-daily oral estrogen therapy for treatment of vasomotor symptoms associated with ... -Manufacturer.com

Bioidentical and natural is the debate  -  Nov 24, 2006
Belleville News-Democrat,The prescription products Cenestin and Enjuvia are conjugated estrogens that are laboratory-manufactured from plants. This estrogen is derived from natural

Plan B(R) OTC Now Available in Pharmacies Nationwide  -  Nov 19, 2006
Drug Newswire (press release),These include the SEASONIQUE(TM) extended-regimen oral contraceptive; Mircette(R) oral contraceptive; ENJUVIA(TM) hormone therapy; and the ParaGard(R) IUC.

Medpharm: FDA approves Plan B, who owns it?  Aug 25, 2006
This includes five oral contraceptives, including Plan B, and ENJUVIA, a once-daily oral estrogen therapy for treatment of vasomotor symptoms associated with ... -Manufacturer.com

Barr Reports GAAP Earnings of $3.12 Per Share for Fiscal 2006 and ...  Aug 15, 2006
Among the other highlights for fiscal 2006 were the launch of our ENJUVIA(TM) hormone therapy, approval for our SEASONIQUE(TM) extended-cycle oral ... -Finanzen.net

Fact Sheet of Barr Pharmaceuticals, Inc. And PLIVA DD  Jun 27, 2006
Cytostatics, APIs SEASONALE(R) Extended-Cycle Oral Contraceptive, SEASONIQUE(TM) Extended-Cycle Oral Contraceptive, ParaGard(R) IUD, ENJUVIA(TM) Hormone ... -Black Enterprise

Fact Sheet of Barr Pharmaceuticals, Inc. and PLIVA dd  Jun 26, 2006
Cytostatics, APIs SEASONALE® Extended-Cycle Oral Contraceptive, SEASONIQUE(TM) Extended-Cycle Oral Contraceptive, ParaGard® IUD, ENJUVIA(TM) Hormone Therapy ... -Yahoo! News



Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Now ...  May 8, 2006
..., today announced that the Company's ENJUVIA(TM) (synthetic conjugated estrogens, B) tablets are now available in pharmacies nationwide. ... - International News Service

Duramed Pharma Says Its ENJUVIA Now Available In Pharmacies ...  May 8, 2006
...(BRL | charts | news | PowerRating)'s subsidiary, Duramed Pharmaceuticals Inc, revealed that its ENJUVIA tablets are now available in pharmacies nationwide. ... - Trading Markets

Barr introduces a plant-derived drug to ease menopause  May 9, 2006
Barr's subsidiary, Duramed Pharmaceuticals Inc., announced availability of its Enjuvia hormone replacement therapy Monday at the annual meeting of the American ... - NorthJersey.com

Duramed debuts estrogen tablet for women  May 9, 2006
Duramed Pharmaceuticals is launching a nationwide rollout of Enjuvia, a synthetic estrogen tablet to treat menopausal symptoms. ... - Milwaukee Business Journal

Daily Briefing  May 9, 2006
Barr subsidiary Duramed Pharmaceuticals announced the availability of its Enjuvia hormone replacement therapy Monday at the annual meeting of the American ... - The News Journal

Barr Launches Menopause Treatment  May 8, 2006
...symptoms such as hot flashes and night sweats.Barr's subsidiary, Duramed Pharmaceuticals Inc., announced availability of its Enjuvia hormone replacement ... - WJLA

Barr launches menopause treatment  May 8, 2006
Enjuvia is made from a blend of 10 synthetic estrogen substances derived from plants. ... It plans to begin promoting Enjuvia to health care providers in mid-May. ... - Seattle Post Intelligencer

Watson Pharmaceuticals Q1 EPS Declines On Lower Brand Product ...  May 9, 2006
Barr Pharmaceutical's subsidiary, Duramed Pharmaceuticals Inc., recently revealed that its Enjuvia tablets for treatment of moderate-to-severe vasomotor ... - Trading Markets

DAILY CHECKUP  May 10, 2006
...flashes and night sweats. Enjuvia is made from a blend of 10 synthetic estrogen substances derived from plants. The once-daily pills ... - Kentucky.com

Barr Reports Third Quarter Fiscal 2006 GAAP Earnings of $0.70 Per ...  May 4, 2006
We also invested in preparing for the launch of our Enjuvia(TM) hormone therapy product line in April and submitted our labeling for our SEASONIQUE(TM) extended ... - PR Newswire



Barr Reports Second Quarter Fiscal 2006 GAAP Earnings of $0.88 Per ...  Feb 7, 2006
...our investment in marketing SEASONALE(R) through television and print advertising and began preparations for the anticipated launch of our Enjuvia(TM) hormone ... - PR Newswire

UPDATE 1-Barr hormone ad was misleading, US FDA says  Jan 18, 2006
...years. The company plans to stop promoting Cenestin after the expected launch of another Barr estrogen therapy, Enjuvia, she said. ... - Reuters

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional